• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.

作者信息

Flegel K M, Hanley J

机构信息

Department of Medicine, McGill University, Montreal, Canada.

出版信息

Stroke. 1989 Aug;20(8):1000-4. doi: 10.1161/01.str.20.8.1000.

DOI:10.1161/01.str.20.8.1000
PMID:2756532
Abstract

Factors associated with stroke and other cardiac embolic events in subjects with nonrheumatic atrial fibrillation were examined in a retrospective study of 91 patients from a teaching hospital clinic. There were 28 first strokes during 355 person-years of follow-up (7.9 per 100 person-years). Patients who had experienced one or more previous events were approximately 2.3 times more likely to have a subsequent event (hazard ratio 2.3, 95% confidence interval 1.5-3.4) than patients who had experienced no events. A univariate analysis of factors associated with a first stroke of any cause or other embolic event showed that age of greater than 75 years (hazard ratio 2.5) and systolic blood pressure of greater than 160 mm Hg (hazard ratio 6.4) were significant factors. After adjusting for the effect of age and systolic blood pressure, previous events still carried an increased risk for subsequent events. Subject with nonrheumatic atrial fibrillation who have had one or more embolic events are at high risk of further emboli. They require special consideration when treatment is being planned.

摘要

相似文献

1
Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.
Stroke. 1989 Aug;20(8):1000-4. doi: 10.1161/01.str.20.8.1000.
2
Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation.非瓣膜性心房颤动中左心房自发显影的预后意义
J Am Coll Cardiol. 1994 Sep;24(3):755-62. doi: 10.1016/0735-1097(94)90025-6.
3
[SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].[SFAAT:的里雅斯特地区非风湿性慢性房颤研究。一项入组研究的结果]
G Ital Cardiol. 1995 Feb;25(2):173-82.
4
Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.肥厚型心肌病中的卒中和栓塞事件:非房颤患者的风险分层
Stroke. 2016 Apr;47(4):936-42. doi: 10.1161/STROKEAHA.115.012130. Epub 2016 Mar 3.
5
Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries.心房颤动作为中风的一个风险因素:一项针对住院医疗保险受益人的回顾性队列研究。
Am J Public Health. 1998 Mar;88(3):395-400. doi: 10.2105/ajph.88.3.395.
6
Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.经食管超声心动图评估心房颤动患者的栓塞风险。ELAT研究组。左心房血栓中的栓塞情况。
Ann Intern Med. 1998 Apr 15;128(8):630-8. doi: 10.7326/0003-4819-128-8-199804150-00004.
7
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study.非风湿性心房颤动患者中风的危险因素:一项病例对照研究。
Am J Med. 1991 Aug;91(2):156-61. doi: 10.1016/0002-9343(91)90008-l.
8
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.监测到的房颤持续时间可预测植入抗心动过速起搏器的心动过缓合并房颤患者的动脉栓塞事件。
J Am Coll Cardiol. 2005 Nov 15;46(10):1913-20. doi: 10.1016/j.jacc.2005.07.044. Epub 2005 Oct 24.
9
The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.阿司匹林对非风湿性心房颤动患者中风风险的影响:BAATAF研究。
Am Heart J. 1992 Dec;124(6):1567-73. doi: 10.1016/0002-8703(92)90074-6.
10
Recurrence of embolic stroke in non-valvular atrial fibrillation (NVAF). An autopsy study.
Acta Neurol Scand. 1989 Aug;80(2):123-9. doi: 10.1111/j.1600-0404.1989.tb03853.x.

引用本文的文献

1
Outcomes and Disease Management in Patients With Atrial Fibrillation ≥80 Years: Data From a Consecutive 11-Year Real-World Registry.80岁及以上心房颤动患者的结局与疾病管理:来自连续11年真实世界注册研究的数据
J Am Heart Assoc. 2025 Feb 18;14(4):e036832. doi: 10.1161/JAHA.124.036832. Epub 2025 Feb 8.
2
Atrial Fibrillation in Older People: Concepts and Controversies.老年人的心房颤动:概念与争议
Front Med (Lausanne). 2019 Aug 8;6:175. doi: 10.3389/fmed.2019.00175. eCollection 2019.
3
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications in Thromboprophylaxis in the Era of Novel Oral Anticoagulants.
年龄作为心房颤动患者中风的危险因素:新型口服抗凝剂时代在血栓预防中的意义。
J Atr Fibrillation. 2013 Jun 30;6(1):783. doi: 10.4022/jafib.783. eCollection 2013 Jun-Jul.
4
Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population.低剂量饮用绿茶可降低中国人群心房颤动的发病率。
Oncotarget. 2016 Dec 20;7(51):85592-85602. doi: 10.18632/oncotarget.12243.
5
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin.与华法林相比,达比加群在非瓣膜性心房颤动患者中表现出较低强度的左心房自发显影。
Heart Vessels. 2017 Mar;32(3):326-332. doi: 10.1007/s00380-016-0871-5. Epub 2016 Jul 12.
6
Secondary prognosis after cardioembolic stroke of atrial origin: the role of left atrial and left atrial appendage dysfunction.心房源性心源性栓塞性卒中后的二级预后:左心房及左心耳功能障碍的作用
Clin Cardiol. 2003 Jun;26(6):269-74. doi: 10.1002/clc.4950260606.
7
Atrial fibrillation pearls and perils of management.心房颤动:管理的要点与风险
West J Med. 1996 May;164(5):425-34.
8
Ischemic stroke and atrial fibrillation. A clinical study.缺血性中风与心房颤动。一项临床研究。
Ital J Neurol Sci. 1993 Oct;14(7):571-6. doi: 10.1007/BF02339217.
9
Service provision and use of anticoagulants in atrial fibrillation.心房颤动中抗凝剂的服务提供与使用
BMJ. 1995 Aug 26;311(7004):558-60. doi: 10.1136/bmj.311.7004.558.
10
Perioperative stroke. Part II: Cardiac surgery and cardiogenic embolic stroke.围手术期卒中。第二部分:心脏手术与心源性栓塞性卒中。
Can J Anaesth. 1991 May;38(4 Pt 1):471-88. doi: 10.1007/BF03007584.